Management of Right-Sided Pleural Effusion in Breast Cancer with Lymphangitis Carcinomatosis

Initial Diagnostic and Therapeutic Approach

The American Thoracic Society recommends performing therapeutic thoracentesis to assess symptom relief from dyspnea, with a maximum removal of 1-1.5L of fluid, as dyspnea not improving after drainage confirms lymphangitis carcinomatosis as the primary cause rather than the effusion itself 1
Therapeutic thoracentesis should be performed in virtually all dyspneic patients with malignant pleural effusions to determine its effect on breathlessness and assess rate of recurrence, according to the American College of Chest Physicians 1
An effusion extending to the right fissure represents a moderate-to-large volume, which typically causes dyspnea, as stated by the American Journal of Respiratory and Critical Care Medicine 2, 3

Lymphangitis carcinomatosis causes dyspnea through impaired gas exchange in the lung parenchyma, not mechanical compression from fluid, as reported by the American Journal of Respiratory and Critical Care Medicine 1
If thoracentesis fails to relieve dyspnea, other causes must be investigated, specifically lymphangitis carcinomatosis, atelectasis, thromboembolism, and tumor embolism, according to the American College of Chest Physicians 1, 5

Systemic therapy should be the primary treatment for breast cancer effusions, as they respond better to systemic treatment than other tumor types, as recommended by the National Comprehensive Cancer Network 4
Local pleural interventions should only supplement systemic therapy, not replace it, according to the American Society of Clinical Oncology 4
For patients with expandable lung and recurrent symptomatic effusion, either indwelling pleural catheter or chemical pleurodesis can be used as first-line definitive intervention, as stated by the American Thoracic Society 6, 7, 5

Do not perform intercostal tube drainage without pleurodesis, as this has nearly 100% recurrence rate at 1 month and offers no advantage over simple aspiration, as reported by the American College of Chest Physicians 4
Do not remove >1.5L during single thoracentesis to prevent re-expansion pulmonary edema, according to the American Thoracic Society 1, 4

Pleural fluid pH <7.2 predicts poor performance status and shorter survival, as reported by the American Journal of Respiratory and Critical Care Medicine 1